Daxor Corp DXR Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$8.45 down $0.18, 2.09% at close Nov 6
Last close · Previous close $8.63
- 52-week change
- Price only
- Distributions
- Per share, last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$8.45down $1.85, 17.96%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$8.63Nov 5
- Volume8.31KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume13.75KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $8.40 to $14.76; now $8.45
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
DXR trailed the S&P 500 in all 7 periods.
| Period | DXR and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | DXR: down 18.0% S&P 500: down 5.6% | DXR trailed the S&P 500 by 12.4 percentage points Trailed |
| 3M | DXR: down 19.4% S&P 500: down 4.1% | DXR trailed the S&P 500 by 15.3 percentage points Trailed |
| YTD | DXR: down 42.7% S&P 500: up 8.7% | DXR trailed the S&P 500 by 51.4 percentage points Trailed |
| 1Y | DXR: down 35.6% S&P 500: up 10.9% | DXR trailed the S&P 500 by 46.5 percentage points Trailed |
| Long term | ||
| 3Y | DXR: up 5.7% S&P 500: up 75.0% +1.9% vs +20.5% a year | DXR trailed the S&P 500 by 69.3 percentage points Trailed |
| 5Y | DXR: down 26.5% S&P 500: up 67.8% −6.0% vs +10.9% a year | DXR trailed the S&P 500 by 94.3 percentage points Trailed |
| 10Y | DXR: up 8.6% S&P 500: up 313.1% +0.8% vs +15.2% a year | DXR trailed the S&P 500 by 304.5 percentage points Trailed |
$10,000 invested in DXR 10 years ago (Nov 4, 2016) would be worth about $10,864 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
DXR trailed the S&P 500 in all 7 periods.
| Period | DXR and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | DXR: down 18.0% S&P 500: down 5.6% | DXR trailed the S&P 500 by 12.4 percentage points Trailed |
| 3M | DXR: down 19.4% S&P 500: down 4.3% | DXR trailed the S&P 500 by 15.1 percentage points Trailed |
| YTD | DXR: down 42.7% S&P 500: up 7.8% | DXR trailed the S&P 500 by 50.5 percentage points Trailed |
| 1Y | DXR: down 35.6% S&P 500: up 9.7% | DXR trailed the S&P 500 by 45.3 percentage points Trailed |
| Long term | ||
| 3Y | DXR: up 5.7% S&P 500: up 68.8% +1.9% vs +19.1% a year | DXR trailed the S&P 500 by 63.1 percentage points Trailed |
| 5Y | DXR: down 26.5% S&P 500: up 56.9% −6.0% vs +9.4% a year | DXR trailed the S&P 500 by 83.4 percentage points Trailed |
| 10Y | DXR: up 6.8% S&P 500: up 252.6% +0.7% vs +13.4% a year | DXR trailed the S&P 500 by 245.8 percentage points Trailed |
$10,000 invested in DXR 10 years ago (Nov 4, 2016) would be worth about $10,683 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$29.38
Closing high on . Now 71.2% below that record.
Split-adjusted daily closes since Mar 17, 1992.
Stock splits
DXR hasn’t split since its price history begins in 1992.
Valuation
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.030 |
| 2017 | $0.030 |
| 2018 | $0.030 |
| 2019 | $0.000 |
| 2020 | $0.000 |
| 2021 | $0.000 |
| 2022 | $0.000 |
| 2023 | $0.000 |
| 2024 | $0.000 |
| 2025 | $0.000 |
| 2026 (to date) | $0.000 |
Dividend details
- $0.00Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- Dividend yield0.00%Last 12 months
- $0.030Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
About Daxor Corp
Daxor Corporation, is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 ™ (Blood Volume Analyzer), the only diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at leading hospital centers across the U.S., enhancing hospital performance metrics in a broad range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. Daxor has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the U.S. Department of Defense. Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for all.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- New York, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
DXR news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
DXR stock FAQ
What is DXR stock’s price today?
Daxor (DXR) traded at $8.45 at the close on , down $0.18 (2.09%) from the previous close of $8.63. Over the past 52 weeks it has traded between $8.40 and $14.76.
If you invested $1,000 in DXR 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in DXR on would be worth about $1,086 at the close on , a total return of +8.6%. The same $1,000 would be worth $735 if invested five years ago, $644 if invested one year ago, $767 if invested 20 years ago, and $879 if invested 30 years ago. Past performance doesn’t predict future returns.
Does DXR pay a dividend?
Daxor hasn’t paid a dividend in the last twelve months.
What is DXR’s 52-week high and low?
Over the past 52 weeks DXR has traded as low as $8.40 and as high as $14.76. At $8.45 at the close on , it is 42.7% below that high and 0.6% above the low.
What is DXR’s all-time high?
DXR’s highest closing price was $29.38 on , adjusted for stock splits. At $8.45 at the close on , it is 71.2% below that record.
Has DXR stock ever split?
No. DXR hasn’t split since its price history begins in 1992.
How has DXR stock performed?
Including dividends and measured to the close on , DXR has returned −42.7% so far this year and −35.6% over the past year, and −26.5% over five years (−6.0% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Daxor in?
Daxor is in the Healthcare sector and the Medical Instruments & Supplies industry, and is headquartered in New York, USA.
What exchange does DXR trade on?
Daxor trades on the Nasdaq under the ticker symbol DXR. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.